Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CMA1 | P23946 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21940524 | 1.00 | CMA1 (0.34) | CMA1CYP19A1CYP11B2BCAT2 | |
| SCHEMBL363187 | 0.74 | MEN1 (0.49) | CMA1 | |
| SCHEMBL13205175 | 0.74 | MEN1 (0.49) | CMA1 | |
| SCHEMBL3373190 | 0.59 | BCAT2 (0.47) | CYP19A1CYP11B2BCAT2 | |
| SCHEMBL88322 | 0.58 | ALDH1A1 (0.46) | CYP19A1CYP11B2 | |
| SCHEMBL23392597 | 0.57 | PTPRC (0.44) | — | |
| SCHEMBL16270911 | 0.57 | PTPRC (0.44) | — | |
| SCHEMBL27888996 | 0.56 | CYP19A1 (0.52) | CYP19A1CYP11B2 | |
| SCHEMBL28141157 | 0.56 | BCAT2 (0.43) | CYP19A1CYP11B2BCAT2 | |
| SCHEMBL376723 | 0.55 | ALDH1A1 (0.48) | CYP19A1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200131193-A1 | PYRANOQUINAZOLINE DERIVATIVES AND NAPHTHOPYRAN DERIVATIVES | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131193-A1 | PYRANOQUINAZOLINE DERIVATIVES AND NAPHTHOPYRAN DERIVATIVES | PPOX, TYR, NQO1 | CMA1 3729/4885CYP19A1 2177/4885CYP11B2 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.